Download PDF
Thromb Haemost 2002; 87(06): 1085-1086
DOI: 10.1055/s-0037-1613142
Letters to the Editor
Schattauer GmbH

Point Mutations in the Endothelial Protein C Receptor (EPCR) Promoter

Eugenia Biguzzi
1   Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, I.R.C.C.S. Maggiore Hospital and University of Milano, Italy
2   Oklahoma Medical Research Foundation, Howard Hughes Medical Institute, Oklahoma City, Oklahoma, USA
,
Jian-Ming Gu
2   Oklahoma Medical Research Foundation, Howard Hughes Medical Institute, Oklahoma City, Oklahoma, USA
,
Giuliana Merati
1   Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, I.R.C.C.S. Maggiore Hospital and University of Milano, Italy
,
Naomi L. Esmon
2   Oklahoma Medical Research Foundation, Howard Hughes Medical Institute, Oklahoma City, Oklahoma, USA
,
Charles T. Esmon
2   Oklahoma Medical Research Foundation, Howard Hughes Medical Institute, Oklahoma City, Oklahoma, USA
› Author Affiliations
Further Information

Publication History

Received 05 November 2001

Accepted after revision 05 March 2002

Publication Date:
08 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Biguzzi E, Merati G, Liaw PCY, Bucciarelli P, Oganesyan N, Qu Dongfeng, Gu Jian-Ming, Fetiveau R, Esmon CT, Mannucci PM, Faioni EM. A 23 bp insertion in the Endothelial Protein C Receptor (EPCR) gene impairs EPCR function. Thromb Haemost 2001; 86: 945-8.
    Thieme ConnectPubMedSearch in Google Scholar
  • 2 Edgell CJ, McDonald CC, Graham JB. Permanent cell line expressing human factor VHI-related antigen established by hybridization. Proc Natl Acad Sci USA 1983; 80 (12) 3734-7.
    CrossrefPubMedSearch in Google Scholar
  • 3 Dignam JD, Lebovitz RM, Roeder R. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983; 11: 1475-89.
    CrossrefPubMedSearch in Google Scholar